CoChat

The Multifaceted Role of Regulatory T Cells in Breast Cancer

Open access
Kos, Kevin, de Visser, Karin E. · 2021 · Annual Review of Cancer Biology

The DOI matches its Crossref record; 144 of the 145 references it cites were found in a registry or an index.

Abstract

The microenvironment of breast cancer hosts a dynamic cross talk between diverse players of the immune system. While cytotoxic immune cells are equipped to control tumor growth and metastasis, tumor-corrupted immunosuppressive immune cells strive to impair effective immunity and promote tumor progression. Of these, regulatory T cells (T regs), the gatekeepers of immune homeostasis, emerge as multifaceted players involved in breast cancer. Intriguingly, clinical observations suggest that blood and intratumoral T regs can have strong prognostic value, dictated by breast cancer subtype. Accordingly, emerging preclinical evidence shows that T regs occupy a central role in breast cancer initiation and progression and provide critical support to metastasis formation. Here, T regs are not only important for immune escape but also promote tumor progression independent of their immune regulatory capacity. Combining insights into T reg biology with advances made across the rapidly growing field of immuno-oncology is expected to set the stage for the design of more effective immunotherapy strategies.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1146/annurev-cancerbio-042920-104912

Cites

144 of 144 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Tregs modulate their local environment to promote breast cancer progression. Tumor-derived factors such as chemokines, cytokines, and other mediators promote the accumulation and expansion of Tregs in primary breast tumors and metastatic niches. In the TME, Tregs constrain both innate and adaptive immune responses to counteract antitumor immunity. Mechanistically, Tregs can (among other effects) suppress the expression of costimulatory ligands on DCs, release inhibitory modulators that interfere with T cell activation, and are also equipped to induce apoptosis in effector cells (left). However, the effector mechanisms that are engaged in the context of the breast TME remain largely unknown. In addition, Tregs can enhance metastatic progression of cancer cells in tumor-draining lymph nodes (middle) and lungs (right) through tissue-specific mechanisms. These mechanisms include promoting tumor cell survival and migration via secretion of TGF-β, AREG, and RANK-L, as well as inhibiting cytotoxic effector cells. Abbreviations: Breg, regulatory B cell; costim., costimulation; DC, dendritic cell; Gal-1, galectin 1; Grzm B, granzyme B; iNOS, inducible nitric oxide synthase; Mφ, macrophage; NK, natural killer; pTreg, peripheral Treg; TME, tumor microenvironment; Treg, regulatory T cell.
Figure 1 Tregs modulate their local environment to promote breast cancer progression. Tumor-derived factors such as chemokines, cytokines, and other mediators promote the accumulation and expansion of Tregs in primary breast tumors and metastatic niches. In the TME, Tregs constrain both innate and adaptive immune responses to counteract antitumor immunity. Mechanistically, Tregs can (among other effects) suppress the expression of costimulatory ligands on DCs, release inhibitory modulators that interfere with T cell activation, and are also equipped to induce apoptosis in effector cells (left). However, the effector mechanisms that are engaged in the context of the breast TME remain largely unknown. In addition, Tregs can enhance metastatic progression of cancer cells in tumor-draining lymph nodes (middle) and lungs (right) through tissue-specific mechanisms. These mechanisms include promoting tumor cell survival and migration via secretion of TGF-β, AREG, and RANK-L, as well as inhibiting cytotoxic effector cells. Abbreviations: Breg, regulatory B cell; costim., costimulation; DC, dendritic cell; Gal-1, galectin 1; Grzm B, granzyme B; iNOS, inducible nitric oxide synthase; Mφ, macrophage; NK, natural killer; pTreg, peripheral Treg; TME, tumor microenvironment; Treg, regulatory T cell.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 144 references

Research works printed but not linked: 2

  1. Peng GL, 2019, Am. J. Transl. Res., 11, 5039
  2. Wolf AM, 2003, Clin. Cancer Res., 9, 606

Cited by

See all 60

Metadata

Authors
Kos, K., & de Visser, K. E.
Affiliations
  • The Netherlands Cancer Institute (NL)
  • Division of Tumor Biology and Immunology, Oncode Institute, Netherlands Cancer Institute, 1066 CX Amsterdam, The Netherlands;
Venue
Annual Review of Cancer Biology
Published
2021-03-04
Volume
5
Issue
1
Pages
291-310
ISSN
2472-3428 (ISSN-L)
OpenAlex
W3111078720
Cited by
58
References
145
Citations by year
2026: 6 · 2025: 13 · 2024: 16 · 2023: 10 · 2022: 12 · 2021: 1
FWCI
0.56
Type
journal article
Language
en
Open access
Locations
  • Annual Review of Cancer Biology (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • Europe PMC (PubMed Central) (acceptedVersion, cc-by)
  • PubMed Central (acceptedVersion, cc-by)
  • Leiden Repository (Leiden University) (submittedVersion, cc-by)
Funders
  • ZonMw (91819616)
  • Nederlandse Organisatie voor Wetenschappelijk Onderzoek (VICI 91819616, NWO-VICI91819616, 91819616)
  • Oncode Institute
  • FP7 Ideas: European Research Council (615300)
Topics
  • Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
  • Health Sciences › Medicine › Oncology › Cancer Immunotherapy and Biomarkers
  • Life Sciences › Immunology and Microbiology › Immunology › Immune cells in cancer
Keywords
regulatory T cells, breast cancer, tumor microenvironment, immunosuppression, tumor immune evasion, metastasis, breast cancer subtypes, prognostic factors, tumor progression, immunotherapy, immune homeostasis

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: The Multifaceted Role of Regulatory T Cells in Breast Cancer. https://app.cochat.ai/papers/10.1146/annurev-cancerbio-042920-104912
The paper
Kos, K., & de Visser, K. E. (2021). The Multifaceted Role of Regulatory T Cells in Breast Cancer. Annual Review of Cancer Biology. https://doi.org/10.1146/annurev-cancerbio-042920-104912

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.